Study Uncovers Molecular Mechanism of Protein Linked to Early-onset Parkinson’s
A protein called Parkin, which is absent or faulty in many patients with…
Ana is a molecular biologist with a passion for communication and discovery. As a science writer, her goal is to provide readers, in particular patients and healthcare providers, with clear and quality information about the latest medical advances. Ana holds a Ph.D. in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in infectious diseases, epigenetics, and gene expression.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
A protein called Parkin, which is absent or faulty in many patients with…
Blocking a key enzyme responsible for the production of a type of fat can become a potential therapeutic…
Low levels of a specific chaperone protein might be implicated in the development of Parkinson’s disease and Lewy body dementia,…
The Italian version of the scale most often used to determine quality of life in patients with …
A new device that uses just a breath sample might, in the future, help diagnose early-stage…
A perspective article summarizes what researchers have learned so far on the role of LRRK2 mutations…
High-intensity exercise is not only safe and feasible, but it can also delay disease progression in early stage Parkinson’s patients,…
Global Kinetics Corporation has obtained $350,000 in foundation funding to conduct a global clinical trial of its wearable device…
A comprehensive data set of the human brain was developed by researchers at Emory University in Atlanta as…
So much Parkinson’s-related biomarker information has been collected under various research projects that sorting through it for additional clues to…
Get regular updates to your inbox.